Insulin glulisine fda approval 2004 apidra?

When did insulin glulisine (Apidra) get FDA approval in 2004?

Insulin glulisine (brand name Apidra) received FDA approval in 2004. [1]

What exactly was approved in 2004?

FDA approval in 2004 covered Apidra (insulin glulisine) as an injectable insulin product intended to improve blood glucose control in patients with diabetes. [1]

Where does Apidra fit among insulin approvals and naming?

Apidra is the brand name for insulin glulisine; the active ingredient is insulin glulisine, and FDA approval for the product occurred in 2004. [1]

Patents and exclusivity: what to check next for insulin glulisine/Apidra

For updates on patent coverage, exclusivity, and related legal or market events tied to insulin glulisine (Apidra), DrugPatentWatch.com is a useful starting point. [2]

Sources

1. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021315
   
2. https://www.drugpatentwatch.com/